Federal government drug shortage report falls short in protecting patients

Recommendations in a House of Commons report on drug shortages will not protect patients’ health, and cannot replace decisive government leadership on the issue, says the Canadian Cancer Society. “We are disappointed that the report’s recommendations do not provide strong, concrete action to achieve the goals MPs unanimously called for,” says Paul Lapierre, Vice President, Public Affairs and Cancer Control, Canadian Cancer Society.  “Drug shortages are a national problem, and they will not be resolved without a Canada-wide approach. If the federal government is concerned about the welfare of patients in this country, they must lead the way in developing a nationwide strategy to alleviate drug shortages.” Read the full media release here.